Catalyst Wire Dossier Catalyst Wire Dossier

atorvastatin (80 mg, new formulation)

atorvastatin · Pfizer Upjohn / Viatris (sponsor via Pfizer's Upjohn and Mylan merger)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for atorvastatin (80 mg, new formulation), covering 2009-10-15 to 2009-10-15. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study Comparing A New 80 Mg Atorvastatin Tablet To A 80 Mg Atorvastatin Commercial Tablet [Phase 4]

See pricing